Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03156712 · ClinicalTrials.gov registry record · NA
Iron Absorption From Iron-enriched Aspergillus Oryzae
A NA study, sponsored by Iowa State University.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT03156712 is a NA study that has completed, run by Iowa State University. The registered enrollment target is 17 participants.
The verdict
NCT03156712, a NA study, has completed, sponsored by Iowa State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
Ferrous sulfate is rapidly absorbed and the bolus of iron enters blood rather quickly possibly leading to higher concentrations of non-transferrin bound iron which induces oxidative stress. The objective of this study was to determine how quickly iron enters into blood stream from the iron-enriched Asperigillus oryzae (AspironTM, ASP) in contrast to ferrous sulfate. Seventeen healthy, female subjects (18-35 y) were randomized, double blind, cross-over experimental design with three treatments: 10 mg iron as FeSO4 and ASP as well as 20 mg iron as ASP.
Interventions
- DIETARY_SUPPLEMENT Ferrous sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2013-05-29 |
| Est. Completion | 2014-02-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03156712
The ClinicalTrials.gov registry entry for NCT03156712 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Iowa State University, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ferrous sulfate is the first listed.
NCT03156712 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03156712 about?
NCT03156712 is a clinical study titled "Iron Absorption From Iron-enriched Aspergillus Oryzae". Ferrous sulfate is rapidly absorbed and the bolus of iron enters blood rather quickly possibly leading to higher concentrations of non-transferrin bound iron which induces oxidative stress. The objective of this study was to determine how quickly iron enters into blood stream from the iron-enriched ...
What is the current status of trial NCT03156712?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2013-05-29. Estimated completion is 2014-02-13.
What interventions are being tested in trial NCT03156712?
The interventions under investigation include: Ferrous sulfate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03156712?
This trial is sponsored by Iowa State University, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.